{"transactions":[{"id":4638882,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-09T23:07:49.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":0,"derivative":{"exercise_price":32.35,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-26-065566","document":"wk-form4_1791587267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1545439/000162828026065566/wk-form4_1791587267.xml","form_type":"4"}},{"id":4638881,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-09T23:07:49.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":36.32,"value":217920.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":62284.242,"source":{"system":"sec-edgar","filing":"0001628280-26-065566","document":"wk-form4_1791587267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1545439/000162828026065566/wk-form4_1791587267.xml","form_type":"4"}},{"id":4638880,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-09T23:07:49.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":32.35,"value":194100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":68284.242,"source":{"system":"sec-edgar","filing":"0001628280-26-065566","document":"wk-form4_1791587267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545439/000162828026065566/wk-form4_1791587267.xml","form_type":"4"}},{"id":739330,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-13T01:07:46.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":6115,"price":23.5,"value":143702.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026."}],"balance_after":62284.242,"source":{"system":"sec-edgar","filing":"0001628280-26-043009","document":"wk-form4_1781312864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043009/wk-form4_1781312864.xml","form_type":"4"}},{"id":747589,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-05T21:57:16.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3187,"price":22.32,"value":71133.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":68399.242,"source":{"system":"sec-edgar","filing":"0001628280-26-041332","document":"wk-form4_1780696632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026041332/wk-form4_1780696632.xml","form_type":"4"}},{"id":904816,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:03.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":19273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":71586.242,"source":{"system":"sec-edgar","filing":"0001628280-26-008076","document":"wk-form4_1771016519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026008076/wk-form4_1771016519.xml","form_type":"4"}},{"id":921281,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-03T23:24:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":20.81,"value":83240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.35 to $21.28, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3."}],"balance_after":52313.242,"source":{"system":"sec-edgar","filing":"0001628280-26-005158","document":"wk-form4_1770161045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005158/wk-form4_1770161045.xml","form_type":"4"}},{"id":921280,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-03T23:24:09.000Z","date":"2026-01-30","kind":"tax_withholding","planned":true,"acquired":false,"shares":2751,"price":20.54,"value":56505.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":56313.242,"source":{"system":"sec-edgar","filing":"0001628280-26-005158","document":"wk-form4_1770161045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005158/wk-form4_1770161045.xml","form_type":"4"}},{"id":945856,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:45.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1416,"price":24.24,"value":34323.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":59064.242,"source":{"system":"sec-edgar","filing":"0001628280-26-000967","document":"wk-form4_1767738641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000967/wk-form4_1767738641.xml","form_type":"4"}},{"id":945855,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:45.000Z","date":"2026-01-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":159,"price":24.46,"value":3889.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025."}],"balance_after":60480.242,"source":{"system":"sec-edgar","filing":"0001628280-26-000967","document":"wk-form4_1767738641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000967/wk-form4_1767738641.xml","form_type":"4"}},{"id":1120978,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-06-05T21:40:22.000Z","date":"2025-06-04","kind":"sale","planned":false,"acquired":false,"shares":5578.335,"price":26.21,"value":146208.16035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2."}],"balance_after":59564,"source":{"system":"sec-edgar","filing":"0001396814-25-000069","document":"wk-form4_1749159397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000069/wk-form4_1749159397.xml","form_type":"4"}},{"id":1120977,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-06-05T21:40:22.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3374,"price":26.4,"value":89073.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":65142.335,"source":{"system":"sec-edgar","filing":"0001396814-25-000069","document":"wk-form4_1749159397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000069/wk-form4_1749159397.xml","form_type":"4"}},{"id":1284012,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-02-04T23:25:23.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":30600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":68516.335,"source":{"system":"sec-edgar","filing":"0001396814-25-000029","document":"wk-form4_1738711516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000029/wk-form4_1738711516.xml","form_type":"4"}},{"id":1309857,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-01-06T23:22:49.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":159,"price":18.33,"value":2914.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":37916.335,"source":{"system":"sec-edgar","filing":"0001396814-25-000005","document":"wk-form4_1736205763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000005/wk-form4_1736205763.xml","form_type":"4"}},{"id":1480290,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-06-13T22:15:15.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":3970,"price":28.72,"value":114018.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.33 to $29.32, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3."}],"balance_after":38075.335,"source":{"system":"sec-edgar","filing":"0001396814-24-000085","document":"wk-form4_1718316907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000085/wk-form4_1718316907.xml","form_type":"4"}},{"id":1480289,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-06-13T22:15:15.000Z","date":"2024-06-12","kind":"grant","planned":true,"acquired":true,"shares":21360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":42045.335,"source":{"system":"sec-edgar","filing":"0001396814-24-000085","document":"wk-form4_1718316907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000085/wk-form4_1718316907.xml","form_type":"4"}},{"id":1489614,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-06-05T21:10:01.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1843,"price":30.89,"value":56930.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":20685.335,"source":{"system":"sec-edgar","filing":"0001396814-24-000055","document":"wk-form4_1717621792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000055/wk-form4_1717621792.xml","form_type":"4"}},{"id":1687169,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"RIKER LAUREN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-01-04T22:25:59.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":159,"price":32,"value":5088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":22528.335,"source":{"system":"sec-edgar","filing":"0001396814-24-000014","document":"wk-form4_1704407150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000014/wk-form4_1704407150.xml","form_type":"4"}},{"id":1832747,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-07-08T00:04:21.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":643,"price":38.91,"value":25019.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.67 to $39.40, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 643.335 shares of common stock acquired under the issuer's employee stock purchase plan in June 2023."}],"balance_after":22687.335,"source":{"system":"sec-edgar","filing":"0001209191-23-041865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123041865/doc4.xml","form_type":"4"}},{"id":1851599,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:39:28.000Z","date":"2023-06-14","kind":"grant","planned":true,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":38.74,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-038030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123038030/doc4.xml","form_type":"4"}},{"id":1851598,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-06-16T21:39:28.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":7,"price":39.01,"value":273.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.000 to $39.010, inclusive."}],"balance_after":22687,"source":{"system":"sec-edgar","filing":"0001209191-23-038030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123038030/doc4.xml","form_type":"4"}},{"id":1851597,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-06-16T21:39:28.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":5773,"price":38.52,"value":222375.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.000 to $38.995, inclusive."}],"balance_after":22694,"source":{"system":"sec-edgar","filing":"0001209191-23-038030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123038030/doc4.xml","form_type":"4"}},{"id":1851596,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-06-16T21:39:28.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":586,"price":37.47,"value":21957.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.975 to $37.965, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 5."}],"balance_after":28467,"source":{"system":"sec-edgar","filing":"0001209191-23-038030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123038030/doc4.xml","form_type":"4"}},{"id":1851595,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-06-16T21:39:28.000Z","date":"2023-06-14","kind":"grant","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":29053,"source":{"system":"sec-edgar","filing":"0001209191-23-038030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123038030/doc4.xml","form_type":"4"}},{"id":1863598,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-06-08T01:31:00.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":616,"price":37.865,"value":23324.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":19053,"source":{"system":"sec-edgar","filing":"0001209191-23-035262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035262/doc4.xml","form_type":"4"}},{"id":1863597,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2023-06-08T01:31:00.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":591,"price":38.991,"value":23043.681,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022."}],"balance_after":19669,"source":{"system":"sec-edgar","filing":"0001209191-23-035262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035262/doc4.xml","form_type":"4"}},{"id":2238760,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:44:08.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":14600,"derivative":{"exercise_price":59.39,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":14600},"source":{"system":"sec-edgar","filing":"0001209191-22-035231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035231/doc4.xml","form_type":"4"}},{"id":2238759,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-06-08T23:44:08.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":5850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":19852,"source":{"system":"sec-edgar","filing":"0001209191-22-035231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035231/doc4.xml","form_type":"4"}},{"id":2238758,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-06-08T23:44:08.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":1150,"price":61.374,"value":70580.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":14002,"source":{"system":"sec-edgar","filing":"0001209191-22-035231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035231/doc4.xml","form_type":"4"}},{"id":2335017,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T21:00:02.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":9300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":9300},"source":{"system":"sec-edgar","filing":"0001209191-22-018518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122018518/doc4.xml","form_type":"4"}},{"id":2335016,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-03-14T21:00:02.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":900,"price":71.95,"value":64755.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.895 to $72.005, inclusive."}],"balance_after":15152,"source":{"system":"sec-edgar","filing":"0001209191-22-018518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122018518/doc4.xml","form_type":"4"}},{"id":2335015,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-03-14T21:00:02.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":8400,"price":71.14,"value":597576.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.84 to $71.74, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2."}],"balance_after":16052,"source":{"system":"sec-edgar","filing":"0001209191-22-018518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122018518/doc4.xml","form_type":"4"}},{"id":2335014,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-03-14T21:00:02.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":9300,"price":10.81,"value":100533.0,"ownership":{"direct":true},"balance_after":24452,"source":{"system":"sec-edgar","filing":"0001209191-22-018518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122018518/doc4.xml","form_type":"4"}},{"id":2429926,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-21T00:22:49.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":9300,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-004200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122004200/doc4.xml","form_type":"4"}},{"id":2429925,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-01-21T00:22:49.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":2500,"price":64.972,"value":162430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":15152,"source":{"system":"sec-edgar","filing":"0001209191-22-004200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122004200/doc4.xml","form_type":"4"}},{"id":2429924,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-01-21T00:22:49.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":2500,"price":10.81,"value":27025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":17652,"source":{"system":"sec-edgar","filing":"0001209191-22-004200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122004200/doc4.xml","form_type":"4"}},{"id":2438694,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-10T22:32:01.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on December 7, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":61.6,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-002726","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122002726/doc4.xml","form_type":"4"}},{"id":2438693,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2022-01-10T22:32:01.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":15152,"source":{"system":"sec-edgar","filing":"0001209191-22-002726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122002726/doc4.xml","form_type":"4"}},{"id":2621047,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-30T20:21:40.000Z","date":"2021-07-29","kind":"exercise","acquired":false,"shares":90,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":11800,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":90},"source":{"system":"sec-edgar","filing":"0001209191-21-048784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121048784/doc4.xml","form_type":"4"}},{"id":2621046,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-30T20:21:40.000Z","date":"2021-07-28","kind":"exercise","acquired":false,"shares":2410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":11890,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":2410},"source":{"system":"sec-edgar","filing":"0001209191-21-048784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121048784/doc4.xml","form_type":"4"}},{"id":2621045,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-07-30T20:21:40.000Z","date":"2021-07-29","kind":"sale","acquired":false,"shares":90,"price":60.81,"value":5472.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":13152,"source":{"system":"sec-edgar","filing":"0001209191-21-048784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121048784/doc4.xml","form_type":"4"}},{"id":2621044,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-07-30T20:21:40.000Z","date":"2021-07-29","kind":"exercise","acquired":true,"shares":90,"price":10.81,"value":972.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001209191-21-048784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121048784/doc4.xml","form_type":"4"}},{"id":2621043,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-07-30T20:21:40.000Z","date":"2021-07-28","kind":"sale","acquired":false,"shares":2410,"price":60.85,"value":146648.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.81 to $60.858, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13152,"source":{"system":"sec-edgar","filing":"0001209191-21-048784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121048784/doc4.xml","form_type":"4"}},{"id":2621042,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-07-30T20:21:40.000Z","date":"2021-07-28","kind":"exercise","acquired":true,"shares":2410,"price":10.81,"value":26052.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021."}],"balance_after":15562,"source":{"system":"sec-edgar","filing":"0001209191-21-048784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121048784/doc4.xml","form_type":"4"}},{"id":2671406,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:39:29.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":6500,"derivative":{"exercise_price":60.96,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-040092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040092/doc4.xml","form_type":"4"}},{"id":2671405,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-06-12T00:39:29.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":2003,"price":59.85,"value":119879.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.820 to $59.845, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote."}],"balance_after":12731,"source":{"system":"sec-edgar","filing":"0001209191-21-040092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040092/doc4.xml","form_type":"4"}},{"id":2671404,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-06-12T00:39:29.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":14734,"source":{"system":"sec-edgar","filing":"0001209191-21-040092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040092/doc4.xml","form_type":"4"}},{"id":2677111,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-06-08T20:17:55.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":1047,"price":61.037,"value":63905.739,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":12134,"source":{"system":"sec-edgar","filing":"0001209191-21-038894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121038894/doc4.xml","form_type":"4"}},{"id":2781287,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-18T00:03:05.000Z","date":"2021-03-17","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":14300,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-21-021585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121021585/doc4.xml","form_type":"4"}},{"id":2781286,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-18T00:03:05.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":16300,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":1520},"source":{"system":"sec-edgar","filing":"0001209191-21-021585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121021585/doc4.xml","form_type":"4"}},{"id":2781285,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-03-18T00:03:05.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":2000,"price":70.01,"value":140020.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.04, inclusive."}],"balance_after":13181,"source":{"system":"sec-edgar","filing":"0001209191-21-021585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121021585/doc4.xml","form_type":"4"}},{"id":2781284,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-03-18T00:03:05.000Z","date":"2021-03-17","kind":"exercise","acquired":true,"shares":2000,"price":10.81,"value":21620.0,"ownership":{"direct":true},"balance_after":15181,"source":{"system":"sec-edgar","filing":"0001209191-21-021585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121021585/doc4.xml","form_type":"4"}},{"id":2781283,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-03-18T00:03:05.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1520,"price":73.28,"value":111385.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.03 to $73.50, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2."}],"balance_after":13181,"source":{"system":"sec-edgar","filing":"0001209191-21-021585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121021585/doc4.xml","form_type":"4"}},{"id":2781282,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2021-03-18T00:03:05.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1520,"price":10.81,"value":16431.2,"ownership":{"direct":true},"balance_after":14701,"source":{"system":"sec-edgar","filing":"0001209191-21-021585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121021585/doc4.xml","form_type":"4"}},{"id":2977063,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T22:37:44.000Z","date":"2020-11-13","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":17820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-058828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058828/doc4.xml","form_type":"4"}},{"id":2977062,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-11-17T22:37:44.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":3000,"price":63.81,"value":191430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":13181,"source":{"system":"sec-edgar","filing":"0001209191-20-058828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058828/doc4.xml","form_type":"4"}},{"id":2977061,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-11-17T22:37:44.000Z","date":"2020-11-13","kind":"exercise","acquired":true,"shares":3000,"price":10.81,"value":32430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":16181,"source":{"system":"sec-edgar","filing":"0001209191-20-058828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058828/doc4.xml","form_type":"4"}},{"id":3027890,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T23:10:47.000Z","date":"2020-09-16","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":20820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-051034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051034/doc4.xml","form_type":"4"}},{"id":3027889,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-09-17T23:10:47.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":3000,"price":60.34,"value":181020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.975 to $60.88, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13181,"source":{"system":"sec-edgar","filing":"0001209191-20-051034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051034/doc4.xml","form_type":"4"}},{"id":3027888,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-09-17T23:10:47.000Z","date":"2020-09-16","kind":"exercise","acquired":true,"shares":3000,"price":10.81,"value":32430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":16181,"source":{"system":"sec-edgar","filing":"0001209191-20-051034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051034/doc4.xml","form_type":"4"}},{"id":3058362,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-13T20:35:14.000Z","date":"2020-08-11","kind":"exercise","acquired":false,"shares":8180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months."}],"balance_after":0,"derivative":{"exercise_price":10.34,"expiration_date":"2021-05-10","underlying":"Common Stock","underlying_shares":8180},"source":{"system":"sec-edgar","filing":"0001209191-20-046610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120046610/doc4.xml","form_type":"4"}},{"id":3058361,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-08-13T20:35:14.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":8180,"price":60.5,"value":494890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.495 to $60.53, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 548 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020."}],"balance_after":13181,"source":{"system":"sec-edgar","filing":"0001209191-20-046610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120046610/doc4.xml","form_type":"4"}},{"id":3058360,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-08-13T20:35:14.000Z","date":"2020-08-11","kind":"exercise","acquired":true,"shares":8180,"price":10.34,"value":84581.2,"ownership":{"direct":true},"balance_after":20813,"source":{"system":"sec-edgar","filing":"0001209191-20-046610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120046610/doc4.xml","form_type":"4"}},{"id":3094915,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T01:20:14.000Z","date":"2020-06-29","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months."}],"balance_after":8180,"derivative":{"exercise_price":10.34,"expiration_date":"2021-05-10","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-20-039978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039978/doc4.xml","form_type":"4"}},{"id":3094914,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-07-02T01:20:14.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":2000,"price":50.34,"value":100680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":12633,"source":{"system":"sec-edgar","filing":"0001209191-20-039978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039978/doc4.xml","form_type":"4"}},{"id":3094913,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-07-02T01:20:14.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":2000,"price":49.34,"value":98680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":14633,"source":{"system":"sec-edgar","filing":"0001209191-20-039978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039978/doc4.xml","form_type":"4"}},{"id":3094912,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-07-02T01:20:14.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":2000,"price":48.72,"value":97440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":16633,"source":{"system":"sec-edgar","filing":"0001209191-20-039978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039978/doc4.xml","form_type":"4"}},{"id":3094911,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-07-02T01:20:14.000Z","date":"2020-06-29","kind":"exercise","acquired":true,"shares":6000,"price":10.34,"value":62040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":18633,"source":{"system":"sec-edgar","filing":"0001209191-20-039978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120039978/doc4.xml","form_type":"4"}},{"id":3113035,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:33:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":12000,"derivative":{"exercise_price":47.65,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-036051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036051/doc4.xml","form_type":"4"}},{"id":3113034,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-06-11T22:33:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":12633,"source":{"system":"sec-edgar","filing":"0001209191-20-036051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036051/doc4.xml","form_type":"4"}},{"id":3118204,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-06-09T01:08:34.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":1752,"price":48.37,"value":84744.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.37 to $48.45, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7833,"source":{"system":"sec-edgar","filing":"0001209191-20-035174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120035174/doc4.xml","form_type":"4"}},{"id":3118203,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-06-09T01:08:34.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":879,"price":46.331,"value":40724.949,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":9585,"source":{"system":"sec-edgar","filing":"0001209191-20-035174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120035174/doc4.xml","form_type":"4"}},{"id":3138728,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-21T23:19:54.000Z","date":"2020-05-21","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months."}],"balance_after":14180,"derivative":{"exercise_price":10.34,"expiration_date":"2021-05-10","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-031513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120031513/doc4.xml","form_type":"4"}},{"id":3138727,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-21T23:19:54.000Z","date":"2020-05-19","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months."}],"balance_after":16180,"derivative":{"exercise_price":10.34,"expiration_date":"2021-05-10","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-031513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120031513/doc4.xml","form_type":"4"}},{"id":3138726,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-05-21T23:19:54.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":2000,"price":45.26,"value":90520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.03 to $45.49, inclusive."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-20-031513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120031513/doc4.xml","form_type":"4"}},{"id":3138725,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-05-21T23:19:54.000Z","date":"2020-05-21","kind":"exercise","acquired":true,"shares":2000,"price":10.34,"value":20680.0,"ownership":{"direct":true},"balance_after":12464,"source":{"system":"sec-edgar","filing":"0001209191-20-031513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120031513/doc4.xml","form_type":"4"}},{"id":3138724,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-05-21T23:19:54.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":2000,"price":42.81,"value":85620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.79 to $42.85, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-20-031513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120031513/doc4.xml","form_type":"4"}},{"id":3138723,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-05-21T23:19:54.000Z","date":"2020-05-19","kind":"exercise","acquired":true,"shares":2000,"price":10.34,"value":20680.0,"ownership":{"direct":true},"balance_after":12464,"source":{"system":"sec-edgar","filing":"0001209191-20-031513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120031513/doc4.xml","form_type":"4"}},{"id":3276385,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T21:41:23.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":23820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-008769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008769/doc4.xml","form_type":"4"}},{"id":3276384,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-12T21:41:23.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":1000,"price":49.81,"value":49810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-20-008769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008769/doc4.xml","form_type":"4"}},{"id":3276383,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-12T21:41:23.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":1000,"price":48.81,"value":48810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":11464,"source":{"system":"sec-edgar","filing":"0001209191-20-008769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008769/doc4.xml","form_type":"4"}},{"id":3276382,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-12T21:41:23.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":1000,"price":47.81,"value":47810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":12464,"source":{"system":"sec-edgar","filing":"0001209191-20-008769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008769/doc4.xml","form_type":"4"}},{"id":3276381,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-12T21:41:23.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":3000,"price":10.81,"value":32430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":13464,"source":{"system":"sec-edgar","filing":"0001209191-20-008769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008769/doc4.xml","form_type":"4"}},{"id":3281721,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T23:19:44.000Z","date":"2020-02-07","kind":"exercise","acquired":false,"shares":170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":26820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":170},"source":{"system":"sec-edgar","filing":"0001209191-20-008074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008074/doc4.xml","form_type":"4"}},{"id":3281720,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T23:19:44.000Z","date":"2020-02-06","kind":"exercise","acquired":false,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":26990,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":830},"source":{"system":"sec-edgar","filing":"0001209191-20-008074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008074/doc4.xml","form_type":"4"}},{"id":3281719,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-10T23:19:44.000Z","date":"2020-02-07","kind":"sale","acquired":false,"shares":170,"price":46.81,"value":7957.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-20-008074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008074/doc4.xml","form_type":"4"}},{"id":3281718,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-10T23:19:44.000Z","date":"2020-02-07","kind":"exercise","acquired":true,"shares":170,"price":10.81,"value":1837.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10634,"source":{"system":"sec-edgar","filing":"0001209191-20-008074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008074/doc4.xml","form_type":"4"}},{"id":3281717,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-10T23:19:44.000Z","date":"2020-02-06","kind":"sale","acquired":false,"shares":830,"price":46.81,"value":38852.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-20-008074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008074/doc4.xml","form_type":"4"}},{"id":3281716,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2020-02-10T23:19:44.000Z","date":"2020-02-06","kind":"exercise","acquired":true,"shares":830,"price":10.81,"value":8972.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":11294,"source":{"system":"sec-edgar","filing":"0001209191-20-008074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120008074/doc4.xml","form_type":"4"}},{"id":3330923,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T21:08:05.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":27820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-19-061926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119061926/doc4.xml","form_type":"4"}},{"id":3330922,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-12-26T21:08:05.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":1000,"price":45.92,"value":45920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-19-061926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119061926/doc4.xml","form_type":"4"}},{"id":3330921,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-12-26T21:08:05.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":1000,"price":10.81,"value":10810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":11464,"source":{"system":"sec-edgar","filing":"0001209191-19-061926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119061926/doc4.xml","form_type":"4"}},{"id":3360853,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-23T00:28:43.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":28820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-19-057869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119057869/doc4.xml","form_type":"4"}},{"id":3360852,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-11-23T00:28:43.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":1176,"price":44.14,"value":51908.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.61 to $44.27, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001209191-19-057869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119057869/doc4.xml","form_type":"4"}},{"id":3360851,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-11-23T00:28:43.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":1000,"price":10.81,"value":10810.0,"ownership":{"direct":true},"balance_after":11640,"source":{"system":"sec-edgar","filing":"0001209191-19-057869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119057869/doc4.xml","form_type":"4"}},{"id":3374089,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-12T22:12:04.000Z","date":"2019-11-11","kind":"exercise","acquired":false,"shares":180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":29820,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":180},"source":{"system":"sec-edgar","filing":"0001209191-19-056093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119056093/doc4.xml","form_type":"4"}},{"id":3374088,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-12T22:12:04.000Z","date":"2019-11-11","kind":"exercise","acquired":false,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months."}],"balance_after":18180,"derivative":{"exercise_price":10.34,"expiration_date":"2021-05-10","underlying":"Common Stock","underlying_shares":4820},"source":{"system":"sec-edgar","filing":"0001209191-19-056093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119056093/doc4.xml","form_type":"4"}},{"id":3374087,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-11-12T22:12:04.000Z","date":"2019-11-11","kind":"sale","acquired":false,"shares":5000,"price":43.59,"value":217950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.50 to $43.96, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10640,"source":{"system":"sec-edgar","filing":"0001209191-19-056093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119056093/doc4.xml","form_type":"4"}},{"id":3374086,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-11-12T22:12:04.000Z","date":"2019-11-11","kind":"exercise","acquired":true,"shares":180,"price":10.81,"value":1945.8,"ownership":{"direct":true},"balance_after":15640,"source":{"system":"sec-edgar","filing":"0001209191-19-056093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119056093/doc4.xml","form_type":"4"}},{"id":3374085,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38598,"kind":"person","name":"RIKER LAUREN","position":1,"cik":"0001545439","reported_name":"Riker Lauren Bullaro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-11-12T22:12:04.000Z","date":"2019-11-11","kind":"exercise","acquired":true,"shares":4820,"price":10.34,"value":49838.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 598 shares of common stock acquired under the issuer's employee stock purchase plan in June 2019."}],"balance_after":15460,"source":{"system":"sec-edgar","filing":"0001209191-19-056093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119056093/doc4.xml","form_type":"4"}}],"next_cursor":"2019-11-12T22:12:04.000000Z,3374085"}